Last $0.56 USD
Change Today 0.00 / 0.00%
Volume 32.7K
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

marina biotech inc (MRNA) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/26/14 - $1.81
52 Week Low
11/18/13 - $0.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MARINA BIOTECH INC (MRNA)

Related News

No related news articles were found.

marina biotech inc (MRNA) Related Businessweek News

No Related Businessweek News Found

marina biotech inc (MRNA) Details

Marina Biotech, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of nucleic acid-based therapies to treat orphan diseases. Its pipeline includes CEQ508 that is in clinical program for the treatment of Familial Adenomatous Polyposis, a hereditary condition; and preclinical programs in type 1 myotonic dystrophy and Duchenne’s muscular dystrophy. The company has partnering and licensing agreements with Mirna Therapeutics, Inc.; ProNAi Therapeutics, Inc.; Monsanto Company; Avecia Nitto Denko; Novartis Institutes for Biomedical Research, Inc.; Protiva Biotherapeutics Inc.; and Arcturus Therapeutics, Inc. for the development, supply, and commercialization of its products. It also has a strategic alliance with Rosetta Genomics, Ltd. to identify and develop microRNA-based products to diagnose and treat various neuromuscular diseases and dystrophies. The company was formerly known as MDRNA, Inc. and changed its name to Marina Biotech, Inc. in July 2010. Marina Biotech, Inc. was founded in 1983 and is headquartered in Bothell, Washington.

marina biotech inc (MRNA) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $141.5K
Compensation as of Fiscal Year 2012.

marina biotech inc (MRNA) Key Developments

Marina Biotech, Inc. Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 05:30 PM

Marina Biotech, Inc. Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 05:30 PM. Venue: Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, CA 90049, United States.

Marina Biotech, Inc. Announces Management Changes

The board of directors of Marina Biotech, Inc. announced the appointment of Daniel E. Geffken, as interim chief financial officer. Mr. Geffken replaces Philip C. Ranker, who resigned as interim chief financial officer and secretary of the company effective as of the close of business on December 31, 2013. Mr. Ranker currently serves as a member of the company's board of directors. Mr. Geffken, age 57, is a founder and managing director at Danforth Advisors, LLC, where he has served since 2011. He has worked in both the life science and renewable energy industries for the past 20 years. His work has ranged from early start-ups to publicly traded companies with $1 billion plus market capitalizations.

Marina Biotech, Inc. Announces Auditor Changes

Marina Biotech, Inc. announced that on May 6, 2014, KPMG LLP was informed of its dismissal and that Wolf & Company, P.C. had been engaged as principal accountants. The decision to change accountants was authorized by the Board of Directors. On April 25, 2014, the Board of Directors of the company authorized the engagement of Wolf & Company, P.C. as the company's independent registered public accounting firm for purposes of performing an audit of the company's financial statements for the fiscal years ended December 31, 2012 and December 31, 2013. The company entered into an engagement letter with Wolf on May 12, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRNA:US $0.56 USD 0.00

MRNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MRNA.
View Industry Companies

Industry Analysis


Industry Average

Valuation MRNA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MARINA BIOTECH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at